Lyoprotected nanosphere formulations for paclitaxel controlled delivery.

Lyoprotected nanosphere formulations for paclitaxel controlled delivery.

Item
http://www.wikidata.org/entity/Q40218727
Toxicological considerations when creating nanoparticle-based drugs and drug delivery systemsPaclitaxel loading in PLGA nanospheres affected the in vitro drug cell accumulation and antiproliferative activity.The formulation of aptamer-coated paclitaxel-polylactide nanoconjugates and their targeting to cancer cellsAnticancer Camptothecin-N-Poly(lactic acid) Nanoconjugates with Facile Hydrolysable Linker.Development of Optimized, Inhalable, Gemcitabine-Loaded Gelatin Nanocarriers for Lung Cancer.Inhaled chemotherapy in lung cancer: future concept of nanomedicine.Revisiting the role of sucrose in PLGA-PEG nanocarrier for potential intranasal delivery.Inhalable, large porous PLGA microparticles loaded with paclitaxel: preparation, in vitro and in vivo characterization.Cryoprotection-lyophilization and physical stabilization of rifampicin-loaded flower-like polymeric micellesRole of hydroxypropyl-β-cyclodextrin on freeze-dried and gamma-irradiated PLGA and PLGA-PEG diblock copolymer nanospheres for ophthalmic flurbiprofen delivery
P2860

Lyoprotected nanosphere formulations for paclitaxel controlled delivery.

Item
http://www.wikidata.org/entity/Q40218727
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Lyoprotected nanosphere formulations for paclitaxel controlled delivery.
@en
type
label
Lyoprotected nanosphere formulations for paclitaxel controlled delivery.
@en
prefLabel
Lyoprotected nanosphere formulations for paclitaxel controlled delivery.
@en
P1433
P1476
P2093
P304
P31
P356
P407
P433
P478
P50
P577
P5875
P698
P356
P1433
P1476
Lyoprotected nanosphere formulations for paclitaxel controlled delivery
@en
P2093
P304
P31
P356
P407
P433
P478
P50
P577
P5875
P698